Navigation Links
Embryonic Stem Cell Research Executive Order Places Politics Ahead of Science, Says Michigan Catholic Conference
Date:3/9/2009

LANSING, Mich., March 9 /PRNewswire-USNewswire/ -- Michigan Catholic Conference Vice President for Public Policy Paul A. Long today released the following statement regarding an executive order to be issued by President Obama that permits federal taxpayer funding of embryonic stem cell research:

"President Obama's executive order regrettably places ideology and political posturing ahead of proven scientific therapeutic advancements. There are endless studies and stories of patients who have been treated, even cured of their debilitating condition following stem cell therapies that do not necessitate the destruction of human embryos, yet the president today will sign an executive order that makes every tax-paying American citizen unwittingly complicit in the destruction of human embryos for experimental research.

"In his remarks at the National Prayer Breakfast on February 5, President Obama stated 'There is no God who condones taking the life of an innocent human being. This much we know.' Unfortunately, there is no consistency between this profound statement and today's executive order as destroying human embryos is, in fact, taking the life of an innocent human being."

Michigan Catholic Conference is the official public policy voice of the Catholic Church in this state.


'/>"/>
SOURCE Michigan Catholic Conference
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Leukemia stem cells have more in common with embryonic stem cells than adult stem cells
2. UCI behind worlds first embryonic stem cell study in humans
3. FDA OKs 1st Embryonic Stem Cell Trial
4. Bishops Urge New President to Keep Laws on Conscience Rights, Foreign Aid for Abortion, Embryonic Stem Cell Research
5. Embryonic Stem Cell Research Unethical Waste of Taxpayer Money Says Americans United for Life President
6. New advancements in the use of adult, embryonic stem cells for tissue regeneration
7. Researchers Create Embryonic-Like Stem Cells From Human Testes
8. STEMCELL Technologies Introduces AggreWell™400 for Standardized Embryonic Stem Cell and Induced Pluripotent Stem Cell Research
9. Public funding impacts progress of human embryonic stem cell research
10. Embryonic pathway delivers stem cell traits
11. Embryonic Pathways Induce Stem Cell Traits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... M&S ... Certificate of Conformity for the Smart System® 20/20. CE Certification builds upon M&S's ... standards and specifications such as ANSI, ISO and proven test methods used in ...
(Date:3/27/2017)... PA (PRWEB) , ... March 27, 2017 , ... ... business simulation -centric training, today announced the launch of a new research ... strategy, having the skills needed to execute that strategy, and the actual success ...
(Date:3/27/2017)... ... March 27, 2017 , ... According to the American Cancer ... stages, is more than 95%. Once the cancer spreads to other organs, bones, or ... find out how to avoid this latter group, tune in to Lifestyle Magazine ...
(Date:3/27/2017)... Texas (PRWEB) , ... March 27, 2017 , ... ... at the GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to commemorate ... and will be an opportunity for area-residents to celebrate two great years while ...
(Date:3/25/2017)... PA (PRWEB) , ... March 25, 2017 , ... Getting ... as a public relations partner. , All through the year, Garden Media aims ... press releases, working with key influencers and pitching client’s key messages to ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
(Date:3/27/2017)... , March 27, 2017  Sanderling Ventures, portfolio ... Ethicon, a division of Johnson & Johnson. Torax manufactures ... the treatment of gastro-esophageal reflux disease (GERD). The ... (MSA) technology and the procedure is currently available ... Torax Medical was founded by Sanderling Ventures, ...
(Date:3/27/2017)... TEL AVIV, Israel , March 27, 2017 ... focused on oncology and immunology, announced today that AGI-134, an ... recently announced acquisition of Agalimmune Ltd., will be featured at ... Meeting in Washington, DC to ... ...
Breaking Medicine Technology: